楊菁，生物醫(yī)學(xué)工程研究所研究員，生物醫(yī)學(xué)工程、藥劑學(xué)雙專(zhuān)業(yè)博導(dǎo)。本科畢業(yè)于南京化工大學(xué)高分子化工專(zhuān)業(yè)，獲學(xué)士學(xué)位。2001年獲得中國(guó)協(xié)和醫(yī)科大學(xué)生物醫(yī)學(xué)工程專(zhuān)業(yè)碩士學(xué)位。博士就讀于清華大學(xué)醫(yī)學(xué)部北京協(xié)和醫(yī)學(xué)院生物醫(yī)學(xué)工程專(zhuān)業(yè)，獲博士學(xué)位。從事生物醫(yī)用材料與藥物緩控釋系統(tǒng)在血管再生與修復(fù)方向的研究。2007年升為副研究員，2012年晉升為研究員。

針對(duì)心血管疾病的臨床治療需求，結(jié)合生物醫(yī)用材料的設(shè)計(jì)與藥物緩控釋系統(tǒng)的構(gòu)建，從事血管再生與修復(fù)方向的基礎(chǔ)應(yīng)用研究。

午夜92福利1000,午夜92福利1000,久久国产亚洲高清观看5388,美女不拍网站免费观看,欧美***天天久久综合精品,中文字幕日韩系列中文字幕,综合久久国产九一剧情麻豆,丰满人妻在线免费视频,奶子大逼又嫩操起来真爽

<sub id="ovp77"></sub>

1. Huiyang Li, Xiaoyu Liang, Youlu Chen, Kaijing Liu, Xue Fu, Chuangnian Zhang*, Xiaoli Wang, Jing Yang*. Synergy of antioxidant and M2 polarization in polyphenol-modified konjac glucomannan dressing for remodeling wound. Bioeng. Transl. Med. 2022, e10398. (IF=10.6843)

2. Xu R, Liu K, Wang X, Zhang C, Zhang Y, Yang J. In situ release of IL-2/IL-12 from SiO2-engineered dendritic cells for synergistic immunotherapy. Nanoscale 2022,11;14(31): 11235-11251. (IF=8.3075)

3. Youlu Chen#, Zuoguan Chen#, Jianwei Duan , Liang Gui , Huiyang Li , Xiaoyu Liang , Xinxin Tian , Kaijing Liu , Yongjun Li*, Jing Yang*. H₂O₂-responsive VEGF/NGF gene co-delivery nano-system achieves stable vascularization in ischemic hindlimbs. Journal of Nanobiotechnology 2022, 20:145.（IF=9.4287）

4. Xiaoyu Liang#, Huiyang Li#, Xuanling Li, Xinxin Tian, Aiai Zhang, Qingzhi Luo, Jianwei Duan, Youlu Chen, Liyun Pang, Chen Li, Xingjie Liang, Yong Zeng，Jing Yang*. Highly sensitive H2O2 scavenging nano-bionic system for precise treatment of atherosclerosis, Acta Pharm. Sin. B 2022. (IF =14.9033)

5. Liang Gui#, Youlu Chen#, Yongpeng Diao, Zuoguan Chen, Jianwei Duan, Xiaoyu Liang， Huiyang Li, Kaijing Liu, Yuqing Miao, Qing Gao, Zhichao Li, Jing Yang*, Yongjun Li*. ROS-responsive nanoparticle-mediated delivery of CYP2J2 gene for therapeutic angiogenesis in severe hindlimb ischemia. Mater. Today Bio. 2022,13:100192. (IF=10.7617).

6. Youlu Chen#, Yong Zeng#, Xiaowei Zhu, Lifu Miao, Xiaoyu Liang, Jianwei Duan, Huiyang Li, Xinxin Tian, Liyun Pang, Yongxiang Wei*, Jing Yang*. Significant difference between sirolimus and paclitaxel nanoparticles in anti-proliferation effect in normoxia and hypoxia: The basis of better selection of atherosclerosis treatment. Bioactive Materials 2021, 6(3):880-889. (IF=16.8737)

7. Zuoguan Chen#, Jianwei Duan#, Yongpeng Diao, Youlu Chen, Xiaoyu Liang, Huiyang Li, Yuqing Miao, Qing Gao, Liang Gui, Xiaoli Wang, Jing Yang?, Yongjun Li?. ROS-responsive capsules engineered from EGCG-Zinc networks improve therapeutic angiogenesis in mouse limb ischemia. Bioactive Materials. 2021,6(1):1-11. (IF=16.8737)

8. Jianwei Duan#, Zuoguan Chen#, Xiaoyu Liang, Youlu Chen, Huiyang Li, Xinxin Tian, Mingming Zhang, Xiaoli Wang*, Hongfan Sun, Deling Kong, Yongjun Li*, Jing Yang*. Construction and application of therapeutic metal-polyphenol capsule for peripheral artery disease. Biomaterials. 2020, 255: 120199. (IF=12.479)

9. Xiaowei Zhu#, Hongzhi Xie#, Xiaoyu Liang, Xuanling Li, Jianwei Duan, Yongxia Chen, Ziying Yang, Chao Liu, Cuiwei Wang, Hailing Zhang, Quan Fang, Hongfan Sun, Chen Li, Yongjun Li, Chun Wang, Cunxian Song, Yong Zeng*, Jing Yang*. Bilayered nanoparticles with sequential release of VEGF gene and paclitaxel for restenosis inhibition in atherosclerosis. ACS Appl. Mater. Interfaces. 2017, 9: 27522-27532. (IF=8.097) 

10. Jing Yang#, Yong Zeng#, Chao Zhang, Yongxia Chen, Ziying Yang, Yongjun Li, Xigang Leng, Deling Kong, Xiaoqing Wei*, Hongfan Sun*, Cunxian Song*. The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent.  Biomaterials. 2013,34(6): 1635-1643. (IF=8.312)